| SpectraBase Spectrum ID |
JGvqWsUbZxo |
| Name |
1-(2-Chlorobenzyl)-4-(3,4-dimethylphenyl)piperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
314.154976449 u |
| Formula |
C19H23ClN2 |
| InChI |
InChI=1S/C19H23ClN2/c1-15-7-8-18(13-16(15)2)22-11-9-21(10-12-22)14-17-5-3-4-6-19(17)20/h3-8,13H,9-12,14H2,1-2H3 |
| InChIKey |
FZKXLIAQPJGKBB-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
314.860 g/mol |
| Nominal Mass |
314 u |
| Quality |
964 |
| Retention Index |
2605 |
| SMILES |
C1(N2CCN(CC=3C(=CC=CC3)Cl)CC2)=CC(=C(C=C1)C)C |
| SPLASH |
splash10-004i-4900000000-91b21329a0f630140af5 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1-(2-chlorobenzyl)-4-(3,4-dimethylphenyl) |
| Technique |
GC/MS |
| Wiley ID |
DD2024_011251 |
